BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37310496)

  • 61. Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy.
    Butragueño-Laiseca L; Marco-Ariño N; Troconiz IF; Grau S; Campillo N; García X; Padilla B; Fernández SN; Slöcker M; Santiago MJ
    Clin Microbiol Infect; 2022 Sep; 28(9):1287.e9-1287.e15. PubMed ID: 35390523
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.
    Deep A; Bansal M; Ricci Z
    Blood Purif; 2021; 50(2):150-160. PubMed ID: 32663827
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.
    Raina R; Chakraborty R; Davenport A; Brophy P; Sethi S; McCulloch M; Bunchman T; Yap HK
    Pediatr Nephrol; 2022 Oct; 37(10):2303-2330. PubMed ID: 34668064
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of specialized renal technologists on optimizing delivery of continuous kidney replacement therapy in critical care areas a retrospective study.
    Khater NA; Sadeq AA; Al Absi DT; Simsekler MCE; Khattab IM; Shalaby EA; AbuKhater R; Kashiwagi DT; Andras C; Molesi A; Omar F; Abbas M; Pirayil MS; Anwar S
    Hemodial Int; 2024 Jun; ():. PubMed ID: 38937144
    [TBL] [Abstract][Full Text] [Related]  

  • 65. How to Determine Fluid Management Goals during Continuous Kidney Replacement Therapy in Patients with AKI: Focus on POCUS.
    Beaubien-Souligny W; Trott T; Neyra JA
    Kidney360; 2022 Oct; 3(10):1795-1806. PubMed ID: 36514727
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetic profile of acyclovir in a child receiving continuous kidney replacement therapy for acute liver failure.
    Collignon C; de Marcellus C; Oualha M; Neuranter V; Heilbronner C; Hirt D
    Pediatr Nephrol; 2023 Oct; 38(10):3493-3497. PubMed ID: 36702934
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ceftriaxone Pharmacokinetics and Pharmacodynamic Target Attainment for Three Pediatric Patients Receiving Continuous Kidney Replacement Therapy.
    Hambrick HR; Cervantes F; Dong M; Tang P; Arbough T; Vinks AA; Mizuno T; Goldstein SL; Kaplan J; Girdwood ST
    J Pediatr Pharmacol Ther; 2024 Apr; 29(2):180-187. PubMed ID: 38596427
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders.
    Eminoğlu FT; Öncül Ü; Kahveci F; Okulu E; Kraja E; Köse E; Kendirli T
    Pediatr Nephrol; 2022 Jun; 37(6):1387-1397. PubMed ID: 34693482
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Description of parallel and sequential configurations for concurrent therapeutic plasma exchange and continuous kidney replacement therapy in adults.
    Kaushik M; Liew ZH; Sewa DW; Phua GC; Cao L; Krishnamoorthy TL; Ng SY; Lim AEL; Ng LC; Koniman R; Teo SH; Tan HK;
    J Clin Apher; 2021 Feb; 36(1):211-218. PubMed ID: 33220117
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of the first 24 h of continuous kidney replacement therapy on hemodynamics, ventilation, and analgo-sedation in critically ill children.
    Imberti S; Comoretto R; Ceschia G; Longo G; Benetti E; Amigoni A; Daverio M
    Pediatr Nephrol; 2024 Mar; 39(3):879-887. PubMed ID: 37723304
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kidney Outcomes Following Utilization of Molecular Adsorbent Recirculating System.
    Trautman CL; Khan M; Baker LW; Aslam N; Fitzpatrick P; Porter I; Mao M; Wadei H; Ball CT; Hickson LJ
    Kidney Int Rep; 2023 Oct; 8(10):2100-2106. PubMed ID: 37850016
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Continuous Renal-Replacement Therapy in Critically Ill Children: Practice Changes and Association With Outcome.
    Chen Z; Wang H; Wu Z; Jin M; Chen Y; Li J; Wei Q; Tao S; Zeng Q
    Pediatr Crit Care Med; 2021 Dec; 22(12):e605-e612. PubMed ID: 33965990
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic.
    Nimgaonkar V; Aggarwal C; Berman AT; Gabriel P; Shulman LN; Kucharczuk J; Roy M; Bauml JM; Singh AP; Cohen RB; Langer CJ; Marmarelis ME
    BMC Cancer; 2021 Oct; 21(1):1094. PubMed ID: 34635061
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute paediatric kidney replacement therapies in Europe: demographic results from the EurAKId Registry.
    Guzzo I; de Galasso L; Bayazit AK; Yildizdas D; Schmitt CP; Hayes W; Shroff R; Jankauskiene A; Virsilas E; Longo G; Vidal E; Mir S; Bulut IK; Tkaczyk M; Mencarelli F; Bertulli C; Cvetkovic M; Kostic M; Paglialonga F; Montini G; Yilmaz E; Teixeira A; Atmis B; Schaefer F
    Nephrol Dial Transplant; 2022 Mar; 37(4):770-780. PubMed ID: 34586417
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epidemiology and Outcome of Critically Ill Pediatric Cancer and Hematopoietic Stem Cell Transplant Patients Requiring Continuous Renal Replacement Therapy: A Retrospective Nationwide Cohort Study.
    Raymakers-Janssen PAMA; Lilien MR; Tibboel D; Kneyber MCJ; Dijkstra S; van Woensel JBM; Lemson J; Cransberg K; van den Heuvel-Eibrink MM; Wösten-van Asperen RM;
    Crit Care Med; 2019 Nov; 47(11):e893-e901. PubMed ID: 31464768
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Practice-Level Variation in Telemedicine Use in a Pediatric Primary Care Network During the COVID-19 Pandemic: Retrospective Analysis and Survey Study.
    Schweiberger K; Hoberman A; Iagnemma J; Schoemer P; Squire J; Taormina J; Wolfson D; Ray KN
    J Med Internet Res; 2020 Dec; 22(12):e24345. PubMed ID: 33290244
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association between volume status assessed by bioelectrical impedance analysis, lung ultrasound, or weight change and mortality in patients with sepsisassociated acute kidney injury receiving continuous kidney replacement therapy.
    Park CH; Han SG; Kim HW; Park JT; Han SH; Kim SJ; Kang SW
    Kidney Res Clin Pract; 2024 Jan; 43(1):93-100. PubMed ID: 37933115
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Be aware of acute kidney injury in critically ill children with COVID-19.
    Wang X; Chen X; Tang F; Luo W; Fang J; Qi C; Sun H; Xiao H; Peng X; Shao J
    Pediatr Nephrol; 2021 Jan; 36(1):163-169. PubMed ID: 32844290
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*.
    Wald R; Shariff SZ; Adhikari NK; Bagshaw SM; Burns KE; Friedrich JO; Garg AX; Harel Z; Kitchlu A; Ray JG
    Crit Care Med; 2014 Apr; 42(4):868-77. PubMed ID: 24275513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.